Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism Article (Faculty180)

cited authors

  • Athnaiel, Onella; Job, Greeshm A; Ocampo, Roberto; Teneqexhi, Pamela; Messer, William S; Ragozzino, Micha E

description

  • Autism spectrum disorders (ASD) are a set of neurodevelopmental disorders marked by a lack of social interaction, restrictive interests, and repetitive behaviors. There is a paucity of pharmacological treatments to reduce core ASD symptoms. Various lines of evidence indicate that reduced brain muscarinic cholinergic receptor activity may contribute to an ASD phenotype.

authors

publication date

  • 2022

published in

start page

  • 64

end page

  • 74

volume

  • 25